Status:
COMPLETED
British Randomised Controlled Trial of Atrioventricular (AV) and Interventricular (VV) Optimisation (BRAVO)
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
University of Aberdeen
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Many patients who have cardiac resynchronisation therapy (a type of pacemaker) implanted for heart failure do not have the settings of their device optimised. The most widely available method for opti...
Eligibility Criteria
Inclusion
- Chronic heart failure due to systolic dysfunction
- Biventricular pacemaker implanted
- Give written informed consent
Exclusion
- Lung disease or any condition that would preclude them from walking on a treadmill
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
403 Patients enrolled
Trial Details
Trial ID
NCT01258829
Start Date
December 1 2010
End Date
March 1 2015
Last Update
June 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ICCH, Imperial College London
London, United Kingdom